Benigne Erkrankungen von Ovar und Tube - Teil 1

Bei Neubildungen an den Ovarien handelt es sich häufig um funktionelle Zysten mit meist spontaner Rückbildung. Als weitere Differenzialdiagnosen tumorartiger Läsionen kommen Endometriome, Pelvic Inflammatory Disease und Extrauteringravidität infrage. Auf gutartige Neubildungen von Ovar und Tube sowie das Management von Ovarialtumoren wird in Teil 2 dieses Beitrags eingegangen.

Schlüsselwörter

Ovar - Eileiter - Tube - Ovarialzysten - Ovarialtumoren - Extrauteringravidität - Pelvic Inflammatory Disease - PID

• Literatur

• 1 Timmerman D, Planchamp F, Bourne T. et al. ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors. Int J Gynecol Cancer 2021; 31: 961-982
• 2 Altchek A, Deligdisch L, Kase N. Diagnosis and Management of ovarian Disorders. 2. Amsterdam: Elsevier Science; 2003
• 3 Prat J. Pathology of the Ovary. Philadelphia: Saunders; 2004
• 4 Di Saia DJ, Creasman WT. Clinical Gynecology Oncology. 6. St Louis: Mosby; 2002
• 5 Tanos V, Schenker JG. Ovarian cysts: a clinical dilemma. Gynecol Endocrinol 1994; 8: 59-67
• 6 Grimes DA Jones LB, Lopez LM. et al. Oral contraceptives for functional ovarian cysts. Cochrane Database Syst Rev 2014; (04) CD006134
• 7 Chiaffarino F, Parazzini F, La Vecchia C. et al. Oral contraceptive use and benign gynecologic conditions. A review. Contraception 1998; 57: 11-18
• 8 Rowan K, Meagher S, Teoh M. et al. Corpus luteum across the first trimester: size and laterality as observed by ultrasound. Fertil Steril 2008; 90: 1844-1847
• 9 Gupta N, Dadhwal V, Deka D. et al. Corpus luteum hemorrhage: rare complication of congenital and acquired coagulation abnormalities. J Obstet Gynaecol Res 2007; 33: 376-380
• 10 McClamrock HD, Adashi EY. Gestational hyperandrogenism. Fertil Steril 1992; 57: 257-274
• 11 Alborzi S, Zarei A, Alborzi S. et al. Management of ovarian endometrioma. Clin Obstet Gynecol 2006; 49: 480-491
• 12 Donnez J, Smets M, Jadoul P. et al. Laparoscopic management of peritoneal endometriosis, endometriotic cysts, and rectovaginal adenomyosis. Ann N Y Acad Sci 2003; 997: 274-281
• 13 Saleh A, Tulandi T. Reoperation after laparoscopic treatment of ovarian endometriomas by excision and by fenestration. Fertil Steril 1999; 72: 322-324
• 14 Ronsini C, Iavarone I, Braca E. et al. The Efficiency of Sclerotherapy for the Management of Endometrioma: A Systematic Review and Meta-Analysis of Clinical and Fertility Outcomes. Medicina (Kaunas) 2023; 59: 1643
• 15 Jennings LK, Krywko DM. Pelvic inflammatory Disease. Treasure Island (FL): StatPearls; 2024
• 16 Brun JL, Castan B, de Barbeyrac B. et al. Pelvic inflammatory diseases: Updated French guidelines. J Gynecol Obstet Hum Reprod 2020; 49: 101714
• 17 Ross J, Guaschino S, Cusini M. et al. 2017 European guideline for the management of pelvic inflammatory disease. Int J STD AIDS 2018; 29: 108-114
• 18 Brunham RC, Gottlieb SL, Paavonen J. Pelvic inflammatory disease. N Engl J Med 2015; 372: 2039-2048
• 19 Risser WL, Risser JM, Risser AL. Current perspectives in the USA on the diagnosis and treatment of pelvic inflammatory disease in adolescents. Adolesc Health Med Ther 2017; 8: 87-94
• 20 Romosan G, Valentin L. The sensitivity and specificity of transvaginal ultrasound with regard to acute pelvic inflammatory disease: a review of the literature. Arch Gynecol Obstet 2014; 289: 705-714
• 21 Kamaya A, Shin L, Chen B. et al. Emergency gynecologic imaging. Semin Ultrasound CT MR 2008; 29: 353-368
• 22 Goje O, Markwei M, Kollikonda S. et al. Outcomes of Minimally Invasive Management of Tubo-ovarian Abscess: A Systematic Review. J Minim Invasive Gynecol 2021; 28: 556-564
• 23 Mitchell C, Prabhu M. Pelvic inflammatory disease: current concepts in pathogenesis, diagnosis and treatment. Infect Dis Clin North Am 2013; 27: 793-809
• 24 Workowski KA, Bachmann LH, Chan PA. et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021; 70: 1-187
• 25 Uhl B. Extrauteringravidität (EUG). In: Uhl B. , Hrsg. Gynäkologie und Geburtshilfe compact. Stuttgart: Thieme; 2023: 76-78
• 26 Brezinka C. Sichere und weniger sichere Ultraschallmarker der extrauterinen Schwangerschaft (EUG). J Gynäkol Endokrinol 2019; 29: 145-148
• 27 Mullany K, Minneci M, Monjazeb R. et al. Overview of ectopic pregnancy diagnosis, management, and innovation. Womens Health (Lond) 2023; 19
• 28 Van Calster B, Bobdiwala S, Guha S. et al. Managing pregnancy of unknown location based on initial serum progesterone and serial serum hCG levels: development and validation of a two-step triage protocol. Ultrasound Obstet Gynecol 2016; 48: 642-649
• 29 Sagiv R, Debby A, Feit H. et al. The optimal cutoff serum level of human chorionic gonadotropin for efficacy of methotrexate treatment in women with extrauterine pregnancy. Int J Gynaecol Obstet 2012; 116: 101-104